Journals / Erciyes Medical Journal / 2022 / Cilt: 44 - Sayı: 2

Determination of Ongoing Symptoms, Quality of Life Levels, and Risk Factors in Post-COVID-19 Patients

Pages
208–215
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Considering that post-COVID-19 symptoms can be seen in patients with mild illness at a high rate and for a long period of time, patient follow-up should be given importance especially for the females, elderly, and obese.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Studies have reported that most post-COVID-19 patients experience post-disease symptoms, but the results of these studies have not been interpreted correctly.
📊
Key Findings & Data:The present study aimed to determine the ongoing symptoms and quality of life levels in post-COVID-19 patients.
💡
Conclusion & Impact:Conclusion: Considering that post-COVID-19 symptoms can be seen in patients with mild illness at a high rate and for a long period of time, patient follow-up should be given importance especially for the females, elderly, and obese.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Studies have reported that most post-COVID-19 patients experience post-disease symptoms, but the results of these studies have not been interpreted correctly. The present study aimed to determine the ongoing symptoms and quality of life levels in post-COVID-19 patients. Materials and Methods: This cross-sectional research was carried out with 151 post-COVID-19 patients in Turkey. A sociodemographic data form and the general quality of life scale EQ-5D-5L were used. Results: Most of the participants completed outpatient COVID-19 treatment (93.4%). Of the participants, 84.7% had at least one post-COVID-19 symptom and 41.7% had six or more symptoms. Fatigue (70.9%), joint pain (45.7%), and muscle pain (38.4%) were the most common post-COVID-19 symptoms. The longest-lasting post-COVID-19 symptoms were hair loss (104.2±51.5 days), memory problem (101.9±53.3 days), and depression (96.3±48.6 days). The mean of the visual analog scale was 83.9±16.1 and lower in individuals with six or more post-COVID-19 symptoms (p=0.001). In female participants, post-COVID-19 symptoms increased by 2.7 times (p=0.020). The prevalence of certain COVID-19 symptoms was significantly higher in females (loss of smell, hair loss, and heart palpitation), those aged 40 years and older (intermittent fever), and obese individuals (heart palpitation and intermittent fever). Conclusion: Considering that post-COVID-19 symptoms can be seen in patients with mild illness at a high rate and for a long period of time, patient follow-up should be given importance especially for the females, elderly, and obese.

🔖

Cite This Article

AKOVA, İ., GEDİKLİ, M. A. (2022). Determination of Ongoing Symptoms, Quality of Life Levels, and Risk Factors in Post-COVID-19 Patients. Erciyes Medical Journal, Cilt: 44 - Sayı: 2, 208–215. https://ajindex.com/articles/502100

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. WHO. WHO Coronavirus (COVID-19) dashboard. Available from: URL: https://covid19.who.int/. Accessed Aug 9, 2021
  2. Republic of Turkey Ministry of Health. COVID-19 Information page. Available from: URL: https://covid19.saglik.gov.tr/. Accessed Aug 9, 2021
  3. National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19. Available from: URL: https://www.nice.org.uk/guidance/ng188. Accessed Aug 9, 2021
  4. Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep 2020; 69(30): 993–8
  5. Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol 2021; 93(2): 1013–22
  6. Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA 2020; 324(6): 603–5
  7. Wang X, Xu H, Jiang H, Wang L, Lu C, Wei X, et al. Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study. QJM 2020; 113(9): 657–65
  8. Townsend L, Dowds J, O’Brien K, Sheill G, Dyer AH, O’Kelly B, et al. Persistent poor health after COVID-19 ıs not associated with respiratory complications or ınitial disease severity. Ann Am Thorac Soc 2021; 18(6): 997–1003
  9. Garner P. Covid-19 and fatigue—a game of snakes and ladders. The BMJ opinion. Available from: URL: https://blogs.bmj.com/ bmj/2020/05/19/paul-garner-covid-19-and-fatigue-a-game-of-snakes-and-ladders/. Accessed Feb 19, 2021
  10. The Atlantic. COVID-19 can last for several months: the disease’s “long-haulers” have endured relentless waves of debilitating symptoms – and disbelief from doctors and friends. Available from: URL: https:// www.msn.com/en-gb/news/coronavirus/covid-19-can-last-for-several-months/ar-BB154LME. Accessed Feb 19, 2021
  11. Gemelli Against COVID-19 Post-Acute Care Study Group. PostCOVID-19 global health strategies: the need for an interdisciplinary approach. Aging Clin Exp Res 2020; 32(8): 1613–20
  12. Reenen M, Janssen B. EQ-5D-5L user guide. Basic information on how to use the EQ-5D-5L instrument, Version 2.1. 2015. Available from: URL: https://apersu.ca/wp-content/uploads/20